In summary, our studies as shown here demonstrate that TRIM26 can act as an oncoprotein that promotes the proliferation and growth of CRC cells and xenograft tumor by destabilizing p53 via a ubiquitin-dependent mechanism. This evidence concerns the gene TRIM26 and neoplasm.